Trump Signs Order Aimed At Boosting Women's Health Research
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

For listenersOffer from Amazon

Turn your wind-down time into listening time

  • Thousands of audiobooks, podcasts and originals
  • Listen on your phone, tablet or Echo — also offline
  • Cancel anytime
Try Audible free Free trial for new members
As an affiliate, we earn on qualifying purchases.

President Donald Trump signed an executive order creating a Women’s Health Division at NIH and a White House task force to coordinate research. The order rescinds a Biden-era initiative but sets no specific funding goals; how it will affect research grants and existing programs remains unclear.

President Donald Trump signed an executive order on October 19 creating a Women’s Health Division at the National Institutes of Health and a separate White House task force, aiming to coordinate and expand federal research into women’s health. The order also rescinds a Biden-era initiative and does not set specific funding targets.The order calls for more research into maternal health, mental health, endometriosis, infertility, fibroids and menopause. It also identifies Alzheimer’s disease, heart disease, osteoporosis and stroke as areas of concern, and directs the government to promote diagnostic technology and improve treatment, according to the report and a White House fact sheet.

White House chief of staff Susie Wiles and Health Secretary Robert F. Kennedy Jr. will lead the task force, which Trump said would coordinate across federal agencies and programs. The panel was scheduled to hold its first meeting on Monday. The administration says it plans to use artificial intelligence in the effort, describing that approach as going beyond the Biden initiative.

The order follows discussions involving Melania Trump, the president, Kennedy and other federal health officials. The first lady has promoted the initiative. Trump said it would “promote new research and really go after the understudied diseases affecting women.”

At a glance
announcementWhen: Signed October 19, 2026; the task force…
The developmentTrump signed an executive order establishing new federal structures for women’s health research and rescinding a Biden-era initiative.

Research Priorities, Without Funding Targets

The order sets a federal coordination structure and names conditions that have often received attention in debates about gaps in women’s health research. A dedicated NIH division and White House task force could give agencies a formal venue to align research priorities, but the order specifies no funding goals. Its practical effect will depend in part on whether agencies direct resources toward the listed areas and how they carry out the research agenda.

The policy also changes the federal framework: it revokes a Biden-era initiative that the previous administration said had attracted nearly $1 billion in federal funding, including money from the Defense Department and NIH. That figure describes funding attracted under the earlier effort; the new order does not announce a comparable commitment. The change therefore raises questions about continuity, not just about which conditions receive attention.

Amazon

women's health research books

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

A New Structure Replaces Biden Initiative

The order builds on an existing NIH office rather than creating federal attention to women’s health from scratch. NIH’s Office of Research on Women’s Health was established in 1990 to advance understanding of biological and social factors affecting women’s health and disease. The White House says the new division is intended to improve coordination across government.

In 2023, President Joe Biden signed an executive order launching a federal initiative to improve how the government approaches and funds research into women’s health. The effort was led by then-first lady Jill Biden. Before leaving office, the Bidens said it had drawn nearly $1 billion in federal funding. Trump’s order rescinds that initiative and establishes a task force led by administration officials rather than by the first lady.

The announcement comes amid broader changes to federal research programs. The source report says administration cuts have affected studies focused on women, including grants categorized as having a diversity focus. It also notes that the administration announced last year that the long-running Women’s Health Initiative would close early, then reversed that decision after protests. Those developments provide context for questions about how the new order will operate alongside existing research and funding decisions.

“Beginning today we will change the reality of women’s health.”

— Melania Trump, first lady

Amazon

menopause health tracker

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Funding and Grant Effects Remain Open

The order does not specify how much new money, if any, will be allocated, when the NIH division will be fully operational, or how the task force will measure progress. The White House’s stated ambition to expand research is not the same as a funding commitment.

It is also unclear how the new structures will affect existing NIH offices, ongoing studies and grants, particularly as the administration has cut some scientific research funding. The source report says it was unclear whether the order conflicts with earlier Trump administration actions limiting programs and policies focused on diversity, equity and inclusion. The administration’s claim that its approach goes beyond the Biden effort, including through AI, has not yet been accompanied by detailed implementation plans in the available account.

Amazon

fibroids pain relief products

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Task Force Begins Federal Coordination

The task force was scheduled to hold its first meeting on October 19, the day Trump signed the order. Its work is expected to involve coordination among federal agencies and programs, but the source material does not give a timeline for further meetings or a schedule for implementing the NIH division.

Readers will be watching for details on staffing, research priorities, grant decisions and any dedicated funding. Those steps will show whether the order changes federal research activity in practice and how the administration’s new framework relates to studies and programs already underway.

Amazon

endometriosis support products

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Key Questions

What did Trump’s executive order establish?

It creates a Women’s Health Division at NIH and a separate White House task force intended to coordinate federal research into women’s health.

Which health issues does the order name?

The order calls for more research into maternal and mental health, endometriosis, infertility, fibroids and menopause, as well as Alzheimer’s disease, heart disease, osteoporosis and stroke.

Does the order provide new research funding?

The order does not set specific funding goals. The available source material does not identify a new funding amount.

What happens to the Biden-era initiative?

Trump’s order rescinds the 2023 initiative. The Biden administration said that effort had attracted nearly $1 billion in federal funding; the new order establishes different federal structures.

Who will lead the White House task force?

White House chief of staff Susie Wiles and Health Secretary Robert F. Kennedy Jr. will lead it, according to the report.

Source: rss

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
HALLOWEEN

Halloween Picks

As an affiliate, we earn on qualifying purchases.

You May Also Like

Eledon Pharmaceuticals Surges In Global Coverage

Eledon Pharmaceuticals experiences a significant increase in international media mentions, with 35 reports in a recent window, signaling rising global interest.

Eyepoint Pharmaceuticals Surges In Global Coverage

Eyepoint Pharmaceuticals experiences a surge in international coverage, with 25 mentions in recent media monitoring, highlighting growing interest in its developments.

Manila Leptospirosis Cases Continue To Rise – Outbreak News Today

Leptospirosis cases in Manila are increasing, prompting health officials to monitor the outbreak. The situation remains under investigation with no official cause confirmed.

Taylor Farms Lettuce Cyclospora Outbreak

Health officials confirm Cyclospora contamination in Taylor Farms lettuce linked to outbreak. Details on affected products and next steps remain ongoing.